PARP1/PARP7 dual inhibitor - Duke Street Bio
Latest Information Update: 30 Jun 2023
At a glance
- Originator Duke Street Bio
- Class Antineoplastics; Small molecules
- Mechanism of Action Poly(ADP-ribose) polymerase 7 inhibitors; Poly(ADP-ribose) polymerase-1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer
Most Recent Events
- 19 Jun 2023 Early research in Cancer in United Kingdom (unspecified route) (Duke Street Bio Pipeline, June 2023)